Pirnabine
Pirnabine (SP-304) is a synthetic cannabinoid receptor ligand, which was developed for the treatment of glaucoma.[1]
Identifiers | |
---|---|
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C19H24O3 |
Molar mass | 300.398 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
References
- "New Names". JAMA: The Journal of the American Medical Association. 241: 65. 1979. doi:10.1001/jama.1979.03290270051024.
Phytocannabinoids |
|
---|---|
Endocannabinoids |
|
Synthetic cannabinoids | |
Allosteric CBR ligands |
|
Endocannabinoid enhancers (inactivation inhibitors) |
|
Anticannabinoids (antagonists/inverse agonists/antibodies) |
|
|
Receptor (ligands) |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (modulators) |
| ||||||||||||
Enzyme (modulators) |
| ||||||||||||
Others |
| ||||||||||||
|
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.